Turqoz NDC 50090-7978

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-7978Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-7978Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-7978-0	50090797800	1 KIT in 1 KIT (50090-7978-0)Marketed from May 20, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Turqoz
Generic name (nonproprietary): norgestrel and ethinyl estradiol
Dosage form: Kit
Labeler: A-S Medication Solutions
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202980
Marketing start: Nov 29, 2023
Listing expires: Dec 31, 2027
Identifiers: Product ID 50090-7978_e9b6e23b-8f92-4169-913d-c87015c04122SPL ID e9b6e23b-8f92-4169-913d-c87015c04122SPL set ID e7a05138-91a5-4c66-a915-614576e0805aRxCUI 311359, 748797, 749786, 2665903

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N450090797800 followed by a unit qualifier and the quantity

Package 50090-7978-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 21, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Turqoz is indicated for use by females of reproductive potential to prevent pregnancy. In a study of 1,287 women with a total of 11,085 cycles or 852.7 women-years of usage, the pregnancy rate in women age 15 to 40 years was approximately 1 pregnancy per 100 women-years of use.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202980

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202980
Product	Strength	Form · route	Labeler	Product NDC
Turqoznorgestrel and ethinyl estradiol	—	Kit	Lupin Pharmaceuticals, Inc.	68180-895